Results 251 to 260 of about 197,386 (292)

Progress in homotransplantation of the liver. [PDF]

, 1966
Marchioro, TL, Porter, KA, Starzl, TE
core  

Cascade‐Responsive MXene@Cu‐MOF Heterostructure Integrates Antioxidant Activity, Infection Control, and Vascularization for Tracheal Repair

Advanced Science, EarlyView.
A cascade‐responsive MXene@Cu‐MOF/GelMA hydrogel is engineered as a “skeleton–backpack” platform for extensive tracheal repair. The MXene framework scavenges postoperative ROS and converts NIR light into mild hyperthermia, while the Cu‐MOF component provides pH/NIR‐responsive Cu2+ dosing for infection control, angiogenesis, and chondrogenesis.
Liang Guo, Yingran Shen, Jiaoyu Yi, Juanjuan Li, Ziming Wang, Erji Gao, Siqiang Zheng, Zhe‐Sheng Chen, Bo Tao   +8 more
wiley   +1 more source

A human liver organoids-on-chip for the assessment of drug-induced liver injury. [PDF]

BMC Pharmacol Toxicol
Chen X, Bao F, Liu J, Wang Y, Tao T, Zhang G, Qin J.   +6 more
europepmc   +1 more source

Dual‐Targeting Cuproptosis and Mitophagy via a Flavopiridol‐Copper Nanoplatform Potentiates Immunotherapy Against Uveal Melanoma

Advanced Science, EarlyView.
This study develops a GSH‐responsive nanoplatform, NP@Fla‐Cu, to co‐activate cuproptosis and excessive mitophagy in uveal melanoma. The nanoplatform enhances tumor‐specific copper delivery, depletes antioxidant defenses, and remodels the tumor immune microenvironment.
Hong Ren, Zhihong Deng, Sheng Lu, Jing Zhang, Wenbin Liu, Jia Tan   +5 more
wiley   +1 more source

LincRNA-p21: A Double-Edged Sword in Ethanol-Induced Liver Damage and Its Nanoparticle Solution. [PDF]

Int J Nanomedicine
Wang S, Nie ZC, Liu Y, Zhang ZY, Feng YM, Wang C, Jiang J.   +6 more
europepmc   +1 more source

Tibetan medicine Baxiaga: a systematic review of its historical herbalogical investigation, phytochemical constituents, and pharmacological activities. [PDF]

Front Pharmacol
Fang N, Lu H, Gao H, Ma J, Wangjia R, Chen H, Su J, Zhang Y.   +7 more
europepmc   +1 more source

Editorial: Prevention and treatment of metabolic diseases using bioactive metabolites of herbal medicines also used as foods. [PDF]

Front Pharmacol
Wei RR, Liu WM, Yuan CS, Zhang CL, Sang ZP, Ma QG.   +5 more
europepmc   +1 more source

Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury. [PDF]

EBioMedicine
Monte MJ, Tran TD, Grove JI, Li D, Stephens C, Lucena MI, Andrade RJ, Weber S, Gerbes A, Bjornsson ES, Stirnimann G, Bjornsson HK, Daly AK, Evans A, Ramaiah SK, Paciga SA, Lingaya M, Atallah E, Robles-Diaz M, Samodelov SL, Poetz O, Rosenberg W, Ramage J, Fowell A, Griffiths WJH, Cramp ME, Patel J, Elsharkawy AM, Marin JJG, Kullak-Ublick GA, Aithal GP.   +30 more
europepmc   +1 more source

Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib. [PDF]

In Vivo
Takada S, Umehara K, Watanabe K.
europepmc   +1 more source